Michael Hedvat

Person

Encino, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Untargeted and targeted IL-10 Fc-fusion proteins
- Patent number 12,006,345
- Issue date Jun 11, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...
- Patent number 11,932,675
- Issue date Mar 19, 2024
- Genentech, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,919,958
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind prostate specific membrane antig...
- Patent number 11,919,956
- Issue date Mar 5, 2024
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,851,466
- Issue date Dec 26, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 compositions
- Patent number 11,591,401
- Issue date Feb 28, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in comb...
- Patent number 11,377,477
- Issue date Jul 5, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 11,312,770
- Issue date Apr 26, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,236,170
- Issue date Feb 1, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific immunomodulatory antibodies that bind costimulatory and...
- Patent number 10,981,992
- Issue date Apr 20, 2021
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific immunomodulatory antibodies that bind costimulatory and...
- Patent number 10,793,632
- Issue date Oct 6, 2020
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 10,787,518
- Issue date Sep 29, 2020
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...
- Publication number 20240417466
- Publication date Dec 19, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...
- Publication number 20240294593
- Publication date Sep 5, 2024
- Genentech, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
- Publication number 20240279356
- Publication date Aug 22, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20240218082
- Publication date Jul 4, 2024
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-TROP2 ANTIBODIES
- Publication number 20240059786
- Publication date Feb 22, 2024
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20240026002
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28
- Publication number 20230383012
- Publication date Nov 30, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-MSLN ANTIBODIES
- Publication number 20230340128
- Publication date Oct 26, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20230322961
- Publication date Oct 12, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 X ANTI-PSMA ANTIBODIES
- Publication number 20230265218
- Publication date Aug 24, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD28 COMPOSITIONS
- Publication number 20230257466
- Publication date Aug 17, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...
- Publication number 20230055445
- Publication date Feb 23, 2023
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20230041377
- Publication date Feb 9, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20220204624
- Publication date Jun 30, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28
- Publication number 20220135684
- Publication date May 5, 2022
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...
- Publication number 20220119525
- Publication date Apr 21, 2022
- Xencor, Inc.
- John R. Desjarlais
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD28 COMPOSITIONS
- Publication number 20220119530
- Publication date Apr 21, 2022
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
- Publication number 20220106403
- Publication date Apr 7, 2022
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD28 COMPOSITIONS
- Publication number 20220098306
- Publication date Mar 31, 2022
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS
- Publication number 20210355185
- Publication date Nov 18, 2021
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20210253706
- Publication date Aug 19, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...
- Publication number 20210230243
- Publication date Jul 29, 2021
- Genentech, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNTARGETED AND TARGETED IL-10 FC-FUSION PROTEINS
- Publication number 20210171596
- Publication date Jun 10, 2021
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20210095030
- Publication date Apr 1, 2021
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...
- Publication number 20200140512
- Publication date May 7, 2020
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20190389954
- Publication date Dec 26, 2019
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20190382495
- Publication date Dec 19, 2019
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20190270816
- Publication date Sep 5, 2019
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20190263909
- Publication date Aug 29, 2019
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20180127501
- Publication date May 10, 2018
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michael Hedvat

Person

Patents Grantslast 30 patents

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Untargeted and targeted IL-10 Fc-fusion proteins

PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...

Anti-CD28 compositions

Heterodimeric antibodies that bind prostate specific membrane antig...

Targeted IL-12 heterodimeric Fc-fusion proteins

Anti-CD28 compositions

Bispecific checkpoint inhibitor antibodies

PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in comb...

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Bispecific checkpoint inhibitor antibodies

Bispecific immunomodulatory antibodies that bind costimulatory and...

Bispecific immunomodulatory antibodies that bind costimulatory and...

Bispecific checkpoint inhibitor antibodies

Patents Applicationslast 30 patents

HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...

HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3

ANTI-CD28 X ANTI-PSMA ANTIBODIES

ANTI-CD28 X ANTI-TROP2 ANTIBODIES

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28

ANTI-CD28 X ANTI-MSLN ANTIBODIES

ANTI-CD28 X ANTI-PSMA ANTIBODIES

ANTI-CD28 X ANTI-PSMA ANTIBODIES

ANTI-CD28 COMPOSITIONS

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28

HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIG...

ANTI-CD28 COMPOSITIONS

HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3

ANTI-CD28 COMPOSITIONS

TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PR...

UNTARGETED AND TARGETED IL-10 FC-FUSION PROTEINS

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...